Dare Bioscience Inc (DARE)

[oxnous]

$45 Million can give DARE a lot of runway to get some corporate development news out.

[trendzone]

Running AH's, wonder why, but shorty is paying for it.

[crowin]

holding steady

[jl270301]

Bill & Melinda Gates Foundation gives Dare Bioscience a boost

[jl270301]

Based on the 3 sell side analysts who offered a 12-month price target in the last three months. Analysts predict a(n) 300.63% increase from today.
Strong Buy is based on the overall consensus of 3 analysts who offered ratings over the last three months.

Bill & Melinda Gates Foundation gives Dare Bioscience a boost.

Dare Bioscience stock rockets after new $49 million grant from Bill & Melinda Gates Foundation.

Shares of Dare Bioscience Inc. DARE, -3.72% rocketed 63.1% in very active premarket trading Wednesday, after the California-based health care company said it was awarded a new grant of up to $48.95 million from the Bill & Melinda Gates Foundation. Trading volume spiked up to 18.1 million shares, compared with the full-day average of about 3.7 million shares. The new grant is to support the development and preclinical activities to advance Dare's investigational reversible contraceptive, DARE-LARC1, toward testing in humans. As part of the grant agreement, DARE agreed to make DARE-LARC1 and any other products available at an affordable price to people in developing countries, or in support of the U.S. educational system and public libraries. The stock has lost 10.6% over the past three months through Tuesday, while the iShares Nasdaq Biotechnology

[oxnous]

Great news for a small biotech. To be found by the Gates Foundation is no small thing.

[Surfacetite]

After hrs right.

[trendzone]

Twitter trader blogs dares market shorters to stay in that position, with more news coming that they might also be granted more than the 48.95 M if needed.

?=

DARE Stock: Why Did ‘Gates’ Give Dare Bioscience a $49M Grant?

7/7/2021 11:41am EDT

By William White, InvestorPlace Writer


Dare Bioscience (NASDAQ:DARE) stock is rising higher on Wednesday after revealing a $48.95 million grant from the Bill & Melinda Gates Foundation.

??

Source: Paolo Bona / Shutterstock.com

According to a filing with the U.S. Securities and Exchange Commission (SEC), Dare Bioscience will be using the funds for the development of its DARE-LARC1 product. This is an “investigational user-controlled, long-acting reversible contraceptive.”

Dare Bioscience will receive an initial payment of $11.45 million from the Bill & Melinda Gates Foundation this month. It will get additional payments as it progresses with the development of the contraceptive. The company will also have to return any funds from the grant that it doesn’t use.

The Bill & Melinda Gates Foundation grant also comes with specific conditions that Dare Bioscience has to uphold. That includes making the product affordable and available in developing countries. It must also provide them to the U.S. educational system and public libraries. The information gained from the development of the contraceptive must also be disseminated promptly and broadly according to the Global Access Commitment.

It’s worth noting that Dare Bioscience only has access to the grant for a certain period of time. The company can use the funds in human tests starting on June 30, 2021, and lasting until November 1, 2026.

DARE stock is seeing heavy trading today on the grant news. As of this writing, some 147 million shares have changed hands. That’s a major jump compared to the company’s daily average trading volume of about 2.1 million shares.

DARE stock was up 21.4% as of Wednesday morning.

Investors that are still looking for more stock market news from today should keep scrolling!



There’s still plenty of stock market news to discuss today and InvestorPlace has it covered. That includes the latest news concerning Newegg (NASDAQ:NEGG), Clover Health (NASDAQ:CLOV), and Exela Technologies (NASDAQ:XELA). You can learn more about this at the following links!

More Wednesday Stock Market News

NEGG Stock: The Latest Headlines That Have Grabbed Newegg Investors’ Attention

CLOV Stock: The News That Should Have Clover Health Fans Cheering

XELA Stock: Could Exela Technologies Become the Next GameStop? 7 Things for Investors to Know

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that?InvestorPlace.com’s writers disclose this fact and warn readers of the risks. Read More:?Penny Stocks — How to Profit Without Getting Scammed


?Subscribe 

Most Popular on InvestorPlace

Is Dogecoin Dead? 7 Cryptos Headed Toward the Crypt

Everyone Will Be Calling Lucid Motors the ‘Tesla-Killer’ by July 4, 2022

7 Strong Stocks to Buy for July 2021

Short-Squeeze Stocks: Today’s Top 10 Stocks With High Short Interest

7 Top-Rated REITs to Buy Today

Contact Us

 

Help

 

Careers

 

Advertise With Us

 

Disclosures & Disclaimers

 

Privacy Policy

 

Terms of Use

 

DMCA Policy

Facebook

 

Twitter

 

RSS

Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Copyright © 2021 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

[MDmojo]

where might this go today? not trying to hop in and get an instant bag

[crowin]

last order in at 1.72

Good luck all

[crowin]

averaged down with some 1.83 avge now 1.89

[bcapps66]

And dropping...

[crowin]

1.98

[Chefboy69]

this is on its way back up..

get in now
or pay more later

[ClayTrader]

* * $DARE Video Chart 01-20-2021 * *

Link to Video - click here to watch the technical chart video

[wesley_]

3.83 love it $$$

[TripTrap]

Ha! Very nice...but I was jokingly referring to the dude that posted 14 days ago, post # 1543

All good...DARE up huge pre-market!!

Go DARE!!

[trickledownfacists]

Breaking away AH

[ClayTrader]

* * $DARE Video Chart 01-19-2021 * *

Link to Video - click here to watch the technical chart video

[wesley_]

$2.10 next leg up coming, nice

[GavNBA]

Perhaps

[TripTrap]

DARE..rockin and rollin today!!!
Who would have thunk that would have happened?

[daretobebold]

DARE needs more cash to fund its working capital/R&D/trials, so 6.4M more shares to be issued/sold to Lincoln Park, with additional dilution to existing shareholders.

https://www.cmlviz.com/recent-development/2021/01/07/DARE/dare-bioscience-files-for-offer-sale-of-up-to-6-4-million-shares-by-lincoln-park-capital-fund

[TripTrap]

Funny...looks like DARE is getting ready to make a big move up in the near future and nothing but crickets lately on this board. Oh well...

[Rocketred]

Dare Bioscience participates in a conference call hosted by Maxim Conference call with management will be held on December 22 hosted by Maxim.

Read more at:
https://thefly.com/n.php?id=3215896

[Rocketred]

The analysts of H.C. Wainwright & Co. have rated Dare Bioscience with a Buy rating. The price target was set to $ 5.00. At a current price of $ 1.40 there is upside potential of 257.14%.

https://markets.businessinsider.com/analysts-opinions/dare-bioscience-inc-registered-shs-buy-744516

[Dutchpaul1]

Will bounce back..no worries here.

[ClarkKant]

$DARE -16% on top line results LOL -33% from the news release.

[trickledownfacists]

Seminar tomorrow.

[Eurotradr]

DARE Bioscience Maintains BUY Rating by Analysts - Earnings Tomorrow

https://money.cnn.com/quote/forecast/forecast.html?symb=DARE

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 5.00, with a high estimate of 7.50 and a low estimate of 3.00. The median estimate represents a +362.96% increase from the last price of 1.08.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Dare Bioscience Inc. This rating has held steady since November, when it was unchanged from a Buy rating.

[GUBS59]

Hi all .... can anyone give me an idea as to where they think DARE can go to $$$$ ???

[sky7777]

My guess is, just a nice slow steady climb up and then...Bo

[harry crumb]

Loaded here to. Need some positive events to roll here.$$$

[420man]

Grabbed some..looks ready for major breakout..flippers getting tired..Will add 1.20's IF it dips before run. JMO

[ClayTrader]

* * $DARE Video Chart 07-14-2020 * *

Link to Video - click here to watch the technical chart video

[CoolSoupy]

What a beautiful chart - My God what would you like???

[TheFinalCD]

double DARE ya

[babyeli1]

another good news story this morning at 8am that went under the radar. would like to see a 10cen move to get bact to even

[babyeli1]

two good news stories i 1 week cant move this pos

[babyeli1]

i still think this a dead in the water stock. but it does look kike it may break out for a few cents. then i am bye bye.

[nathanial]

Considering there are 27 million in the O/S and float about 24 million, does any one have any idea why we traded over a million shares today and volume has been above normal for the last few days?

[nathanial]

What's up with all this pre market volume this morning?

94K traded already.

[babyeli1]

very dissapointed in this stock. wish i never got involved with this pos. i saw potential but the more i read about this stock the worse. as a pharmacist i should have realized better. there already is clindamycin vaginal on the market and if bayer wanted to develop any products they could do it on there own.

[nathanial]

424B3 out after the close.

https://www.otcmarkets.com/filing/html?id=14206281&guid=7qnHU6FKjuodc3h

[zj3001]

Wanting on Bayer to state they are interested in continued collaboration. Should have heard something by now.

[babyeli1]

have had dare for a few months. i know this is not a over night stock but even with a 7.50 buy rating noth. what is going on here

[harry crumb]

Not alot happening here, had upside with that news awhile ago but seems stuck at this point

[nathanial]

On the bright side, it did fill the gap from this morning.

[Eurotradr]

Daré Bioscience CEO to Participate in Maxim Group’s Infectious Disease Virtual Conference:

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion during the Infectious Disease Virtual Conference presented by Maxim Group on May 5, 2020. Ms. Johnson will be a member of the panel discussing non-antibiotic anti-infectives, scheduled from 10:30 a.m. to 12:00 p.m. Eastern Time.

During the panel discussion, Ms. Johnson will share insights from the Company’s DARE-BV1 development program. DARE-BV1, a novel thermosetting bio-adhesive hydrogel formulated with clindamycin phosphate 2%, is an investigational product for the treatment of bacterial vaginosis (BV), one of the most common vaginal infections. The Company plans to initiate a Phase 3 study of DARE-BV1 during 2020, have topline data available by the end of the year and submit a new drug application (NDA) for DARE-BV1 with the FDA during the first half of 2021.

For additional information, please visit https://m-vest.com/insights/blog/Infectious-Disease-Virtual-Conference-2020.

[nathanial]

What's with the huge jump after hours today and huge volume?

Heard someone came out with a buy recommendation after the close with a price target of $7.50.